A Phase 2 study of S-237648 in Japanese obese patients with impaired glucose tolerance/type 2 diabetes mellitus and hyperlipidemia

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2015
INTERVENTION: Intervention name : S‐237648 Dosage And administration of the intervention : Oral CONDITION: Obesity PRIMARY OUTCOME: Change in body weight INCLUSION CRITERIA: [Main inclusion criteria] 1.With BMI >=25.0 2.With visceral fat area >=100 cm2 3.Patients who meets following criteria A)Previously diagnosed with glucose intolerance or type 2 diabetes [HbA1c >=6.5% to <9.0% (NGSP)] B)Previously diagnosed as hyperlipidemia with TG >=150 mg/dL and/or HDL‐C <40 mg/dL and/or LDL‐C >=140 mg/dL
Epistemonikos ID: 5ae85cc2d1dce025e847651ea98bf03268b08f53
First added on: Aug 23, 2024